-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$24.0075.18% Upside
Cidara Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. has been rated by research analysts at H.C. Wainwright in the past 90 days.